Zenas BioPharma Inc. (ZBIO) 股价近日遭遇重挫,创下逾四个月以来的新低。此次股价大幅下跌的主要原因是其免疫疾病药物的后期临床试验数据未达市场预期,导致投资者信心受挫。截至最新交易时段,该公司股价当日跌幅高达55%,反映出市场对其药物研发前景的担忧。
Zenas BioPharma Inc. (ZBIO) 股价近日遭遇重挫,创下逾四个月以来的新低。此次股价大幅下跌的主要原因是其免疫疾病药物的后期临床试验数据未达市场预期,导致投资者信心受挫。截至最新交易时段,该公司股价当日跌幅高达55%,反映出市场对其药物研发前景的担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.